The latest announcement follows the recent US Food and Drug Administration (FDA) acceptance of the company’s new drug ...

在Science所评定的2024年度十大科学突破中，还有一项生物医药领域的重大成果，那便是吉利德所开发的Lenacapavir（LEN，来那帕韦）以100%的疗效打破了HIV感染不可控的僵局。

Gilead Sciences has announced that the US Food and Drug Administration (FDA) has accepted its New Drug Application ...

A multi-national, multi-institutional study led by Weill Cornell Medicine investigators found little natural resistance to a ...

日前，生物制药领域迎来了一项重磅新闻，吉利德公司开发的抗HIV药物Lenacapavir（来那帕韦）因其卓越的疗效被评选为《Science》2024年度十大科学突破之一。这一成果也为HIV/AIDS患者带来了希望，惊艳的数据显示，这种药物的疗效达到了100%。这一现象引发了科学界的广泛关注：Lenacapavir究竟为何如此特别？它的独特之处在哪里？

US antivirals giant Gilead Sciences recently announced that the US Food and Drug Administration (FDA) has accepted its New ...

Lenacapavir, a twice yearly injection that prevents HIV transmission, was named the breakthrough medicine of 2024. But without US foreign aid dollars, its delivery to millions worldwide is under ...

Foster City, California Tuesday, February 25, 2025, 16:00 Hrs [IST] ...

A groundbreaking injectable designed to curb the global spread of HIV is now at risk of being delayed due to Donald Trump's ...

Several protesters were arrested Wednesday after U.S. Agency for International Development workers were told via a text ...

Based on the assessment of EMA’s Committee for Medicinal Products for Human Use (CHMP) that twice-yearly lenacapavir for prevention is a product of major interest for public health and ...